Columbia University's Zuckerman Institute

Columbia’s Zuckerman Institute is dedicated to sharing the extraordinary research of our scientists with broad audiences.

https://zuckermaninstitute.columbia.edu/

 

Videos
26:23

Columbia University's Zuckerman Institute

Evolution of SARS-CoV-2 – Delta, Omicron, and More Greek Alphabet(s)

FEATURING Kei Sato
  • 382 views
  • May 20, 2022
  • 2
32:51

Columbia University's Zuckerman Institute

Immunity of SARS-CoV-2 Vaccines Against Omicron

FEATURING Dan Barouch
  • 31 views
  • May 19, 2022
32:05

Columbia University's Zuckerman Institute

Factors That Anticipate Post Acute COVID-19 Sequelae

FEATURING James R Heath
  • 733 views
  • May 19, 2022
  • 2
32:15

Columbia University's Zuckerman Institute

Disruption of Nuclear Architecture as a Mechanism for COVID-19 Induced Anosmia​​​​​​​

FEATURING Stavros Lomvardas
  • 5 views
  • May 19, 2022
29:01

Columbia University's Zuckerman Institute

Do the Placenta and Fetus Respond to SARS-CoV-2 Infection During Pregnancy?

FEATURING Nardhy Gómez-López
  • 17 views
  • April 20, 2022
33:49

Columbia University's Zuckerman Institute

Tracking SARS-CoV-2 Variants in the UK

FEATURING Emma Thomson
  • 15 views
  • April 19, 2022
29:27

Columbia University's Zuckerman Institute

Exosomal ACE2 Neutralizes Broad Variants of SARS-CoV-2

FEATURING Lamiaa El-Shennawy
  • 6 views
  • April 19, 2022
31:11

Columbia University's Zuckerman Institute

In Vitro Pipelines for the Discovery of SARS-CoV-2 Antivirals

FEATURING David C. Schultz
  • 10 views
  • April 19, 2022
25:42

Columbia University's Zuckerman Institute

Alzheimer’s-like Signaling in Brains of COVID-19 Patients

FEATURING Andrew R. Marks
  • 10 views
  • April 19, 2022
17:22

Columbia University's Zuckerman Institute

Decreased SARS-CoV-2 Viral Load Following Inoculation with the BNT162b2 Vaccine

FEATURING Matan Levine
  • 7 views
  • April 19, 2022
26:02

Columbia University's Zuckerman Institute

SARS-CoV-2 Variants Alpha to Omicron: The Response of T-Cells

FEATURING Alba Grifoni
  • 22 views
  • March 22, 2022
  • 1
32:53

Columbia University's Zuckerman Institute

T-Cell Responses in Acute and Persistent COVID-19

FEATURING Alexander Huang
  • 3 views
  • March 22, 2022
30:10

Columbia University's Zuckerman Institute

The Legacy of Maternal SARS-CoV-2 Infection on the Immunology of the Neonate

FEATURING Deena Gibbons
  • 6 views
  • March 22, 2022
34:13

Columbia University's Zuckerman Institute

Can the Neuropathology in COVID-19 Brains Explain the Neuropsychiatric Symptoms of PASC?​​​​​​​

FEATURING James E. Goldman
  • 18 views
  • March 22, 2022
38:28

Columbia University's Zuckerman Institute

Transitioning to the Next Phase of the Pandemic: What Can Implementation Science Teach Us About Barriers to Change, Lifting of Interventions and Strategies for Moving Forward?

FEATURING Westyn Branch-Elliman
  • 5 views
  • March 22, 2022
35:07

Columbia University's Zuckerman Institute

What Is the Link Between COVID-19 and Obesity?

FEATURING Tracey Mclaughlin
  • 13 views
  • March 22, 2022
33:35

Columbia University's Zuckerman Institute

A Single Dose SARS-CoV-2 Antiviral Intervention With a High Barrier to Resistance​​​​​​​

FEATURING Leor Weinberger
  • 7 views
  • March 22, 2022
29:51

Columbia University's Zuckerman Institute

Long-Term Outcomes of SARS-CoV-2 Infection: Immunological Memory and Long COVID-19

FEATURING Onur Boyman
  • 113 views
  • February 23, 2022
31:37

Columbia University's Zuckerman Institute

Local and Systemic Responses to SARS-CoV-2 Infection in Children and Adults

FEATURING Kerstin Meyer
  • 209 views
  • February 23, 2022
  • 1
30:21

Columbia University's Zuckerman Institute

Aberrant Myeloid Cell Responses in Severe COVID-19

FEATURING Leif Erik Sander
  • 7 views
  • February 23, 2022
34:55

Columbia University's Zuckerman Institute

Novel Approaches to Testing for SARS-CoV-2 Infection and Immunity

FEATURING Melanie Ott
  • 97 views
  • February 23, 2022
29:44

Columbia University's Zuckerman Institute

Mental Health Concerns During the COVID-19 Pandemic as Revealed by Helpline Calls

FEATURING Valentin Klotzbücher
  • 165 views
  • February 17, 2022
  • 2
31:37

Columbia University's Zuckerman Institute

Neutralizing Antibodies Against Pandemic Viruses

FEATURING Pamela J. Bjorkman
  • 92 views
  • February 16, 2022
  • 3
29:58

Columbia University's Zuckerman Institute

Emergence and Phenotype of SARS-CoV-2 Omicron

FEATURING Penny Moore
  • 68 views
  • February 16, 2022
29:25

Columbia University's Zuckerman Institute

A Global Effort to Dissect the Human Genetic Basis of Resistance to SARS-CoV-2 Infection

FEATURING András N. Spaan
  • 23 views
  • February 16, 2022
32:09

Columbia University's Zuckerman Institute

Humoral Immune Responses to SARS-CoV-2 Infection or Vaccination

FEATURING Christian Gaebler
  • 73 views
  • February 16, 2022
25:34

Columbia University's Zuckerman Institute

Pre-existing Polymerase-specific T Cells Expand in Abortive Seronegative SARS-CoV-2

FEATURING Mala Maini
  • 21 views
  • January 28, 2022
26:52

Columbia University's Zuckerman Institute

SARS-CoV-2 Re-Infections: Lessons From Other Coronaviruses

FEATURING Lia Van Der Hoek
  • 175 views
  • December 23, 2021
20:56

Columbia University's Zuckerman Institute

Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2

FEATURING David Ho
  • 1,193 views
  • December 23, 2021
  • 2
33:38

Columbia University's Zuckerman Institute

Antiviral Strategy for SARS-CoV-2: Lethal Mutagenesis With Molnupiravir/NHC

FEATURING Ronald Swanstrom
  • 197 views
  • November 19, 2021
  • 2
27:29

Columbia University's Zuckerman Institute

Protective Immunity From T-Cells to SARS-CoV-2 in Previously Infected and Infection-Naive Healthcare Workers

FEATURING Paul Klenerman
  • 132 views
  • November 19, 2021
  • 1
32:35

Columbia University's Zuckerman Institute

What Can Sequence Based Analyses of Natural Selection of SARS-CoV-2 Tell Us About the Past, Present and Future Evolution of the Virus?

FEATURING Sergei L. Kosakovsky Pond
  • 31 views
  • October 29, 2021
26:05

Columbia University's Zuckerman Institute

Understanding the Transmission Dynamics of SARS-CoV-2 Using Mathematical Models

FEATURING Sen Pei
  • 24 views
  • October 29, 2021
31:34

Columbia University's Zuckerman Institute

Structure Guided Design of Coronavirus Vaccines

FEATURING David Veesler
  • 16 views
  • October 29, 2021
37:00

Columbia University's Zuckerman Institute

Network Based Identification and Pharmacological Targeting of Host Cell Master Regulators Induced by SARS-CoV-2 Infection

FEATURING Mariano J. Alvarez
  • 5 views
  • October 29, 2021
24:23

Columbia University's Zuckerman Institute

Pandemic-Scale Phylogenomics for SARS-CoV-2 and Beyond

FEATURING Russ Corbett-Detig
  • 3 views
  • October 29, 2021
26:04

Columbia University's Zuckerman Institute

Autoantibodies in COVID-19: Impact on Disease Outcomes in COVID-19 Patients

FEATURING Aaron Ring
  • 30 views
  • October 7, 2021
21:57

Columbia University's Zuckerman Institute

COVID-19: Building Vaccine Confidence With an Evidence Based Approach

FEATURING Stefanie Friedhoff
  • 53 views
  • October 5, 2021
25:46

Columbia University's Zuckerman Institute

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

FEATURING Ishac Nazy
  • 107 views
  • October 5, 2021
  • 1
22:28

Columbia University's Zuckerman Institute

T Cell Responses Induced by SARS-CoV-2 mRNA Vaccination: How Much Protection is Provided from Severe Infection After the First Dose?

FEATURING Maike Hofmann
  • 156 views
  • September 24, 2021
21:48

Columbia University's Zuckerman Institute

B Cell Response to SARS-CoV-2 Vaccination in Humans

FEATURING Ali H. Ellebedy
  • 127 views
  • September 24, 2021
  • 1
25:49

Columbia University's Zuckerman Institute

SARS-CoV-2 Natural Infection Versus Vaccination: How Does the Strength, Durability, and Antibody Immunity Differ Against Variants?

FEATURING Duane Wesemann
  • 246 views
  • September 24, 2021
  • 2
27:22

Columbia University's Zuckerman Institute

COVID-19 Vaccination in Previously Infected Individuals

FEATURING Nabin Shrestha
  • 4,474 views
  • August 25, 2021
  • 34
19:02

Columbia University's Zuckerman Institute

Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States

FEATURING Kaitlyn Sadtler
  • 95 views
  • August 25, 2021
  • 1
20:32

Columbia University's Zuckerman Institute

SARS-CoV-2: Replication and Sensitivity of the Delta Variant to Antibodies

FEATURING Olivier Schwartz
  • 102 views
  • August 25, 2021
  • 1
23:52

Columbia University's Zuckerman Institute

COVID-19: Evaluating the Effectiveness of Different Interventions From Policies and Recent Trends of Infection Transmission

FEATURING Katelyn Gostic
  • 16 views
  • July 21, 2021
21:48

Columbia University's Zuckerman Institute

COVID-19: What Level of Immune Response Is Sufficient to Protect Us After Vaccination?

FEATURING Miles P. Davenport
  • 3,649 views
  • July 21, 2021
  • 14
24:00

Columbia University's Zuckerman Institute

COVID-19: What Is the Risk of Developing Immune Thrombocytopenia (ITP) After Vaccination? What About Pre-existing ITP Patients?

FEATURING James Bussel
  • 366 views
  • July 21, 2021
  • 2
18:57

Columbia University's Zuckerman Institute

SARS-CoV-2: Can Cytokines’ Level and Their Connection With Immune Cells Determine the Clinical Manifestation and the Infection Outcome?

FEATURING Petter Brodin
  • 7 views
  • July 5, 2021
22:20

Columbia University's Zuckerman Institute

COVID-19: Can CoVac-1 Induce Higher SARS-CoV-2-Specific T-Cell Responses Compared to Approved mRNA Vaccines (Pfizer and Moderna) and Vector Vaccines (AstraZeneca)?

FEATURING Juliane Walz
  • 1,744 views
  • July 5, 2021
  • 9
30:40

Columbia University's Zuckerman Institute

COVID-19 Indoor Safety Guidelines for Airborne Transmission (July 2021 Update): What Factors Can Help Prevent Airborne Spread?

FEATURING Martin Bazant
  • 22 views
  • July 5, 2021
27:32

Columbia University's Zuckerman Institute

Integrating Human and Single Cell Variations in COVID-19

FEATURING John Tsang
  • 1 view
  • July 5, 2021
25:00

Columbia University's Zuckerman Institute

Long COVID-19: Do Patients Who Have Recovered From Acute Respiratory Symptoms Still Have a Higher Risk of Death? How Can Health Systems Prepare for Post COVID-19 Care?

FEATURING Ziyad Al-Aly
  • 1,415 views
  • July 5, 2021
  • 5
26:33

Columbia University's Zuckerman Institute

COVID-19 Pathology to Therapy: Are Calcium-Activated Chloride Channels Causally Involved in COVID-19 Disease?

FEATURING Mauro Giacca
  • 10 views
  • June 2, 2021
  • 1
24:39

Columbia University's Zuckerman Institute

Are Chromatin-Based Inhibition of Inflammatory Gene Programs a Viable Method for Controlling Hyperinflammation in SARS-CoV-2 Infections?

FEATURING Ivan Marazzi
  • 29 views
  • June 2, 2021
26:26

Columbia University's Zuckerman Institute

How Do Pre-Existing Memory B and T Cells Relate to Susceptibility and Disease Outcome of SARS-CoV-2?

FEATURING Scott E. Hensley
  • 1,380 views
  • June 2, 2021
  • 13
17:52

Columbia University's Zuckerman Institute

Effect of Bardoxolone in Participants with SARS-CoV-2: Can It Manipulate the Inflammatory Process? Is There Any Antiviral Efficacy?

FEATURING Thomas Pietschmann
  • 13 views
  • June 2, 2021
25:45

Columbia University's Zuckerman Institute

Is the Transmembrane Protein 41B (TMEM41B) a Potential Target to Fight COVID-19?

FEATURING William Schneider, Heinrich Hoffman
  • 13 views
  • April 26, 2021
23:07

Columbia University's Zuckerman Institute

Predicting Future Zoonotic Events: How Can SARS-CoV-2 Infect Humans Across the Species, Escape the Immunity of Hosts, and Survive?

FEATURING Nels Elde
  • 79 views
  • April 26, 2021
26:26

Columbia University's Zuckerman Institute

COVID Data Models (CoDatMo): Researchers Pool Data of COVID-19 Contributed Epidemiological Models and the Ideas of the Probability of COVID-19 Related Events

FEATURING Breck Beldwin
  • 4 views
  • April 26, 2021
30:20

Columbia University's Zuckerman Institute

Which SARS-CoV-2 Variant is of Most Concern in Vaccine Neutralization?

FEATURING Pei-Yong Shi
  • 31 views
  • March 26, 2021
  • 1
28:28

Columbia University's Zuckerman Institute

Detection of COVID-19 Using Wearables​​​​​​​: Can Wearable Devices Provide Early Detection?

FEATURING Michael Snyder
  • 23 views
  • March 26, 2021
23:14

Columbia University's Zuckerman Institute

Resurgent COVID-19: How Does Age Prioritized Vaccination Affect the Number of Infections?

FEATURING Oliver Ratmann
  • 5 views
  • March 26, 2021
33:12

Columbia University's Zuckerman Institute

SARS-CoV-2 Evolution During Treatment of Chronic Infection: Is Chronic COVID-19 Infection a Source of New Variants?

FEATURING Ravi Gupta
  • 6 views
  • March 26, 2021
34:26

Columbia University's Zuckerman Institute

Identification of SARS-CoV-2 Host Factors Using Multi-Scale Functional Genomics

FEATURING J.T. Poirier
  • 14 views
  • March 24, 2021
13:39

Columbia University's Zuckerman Institute

[PRIVATE] mRNA Vaccine-Elicited Antibodies to SARS-CoV-2 and Circulating Variants: How Does Plasma Neutralizing Activity of Vaccinated Volunteers Compare to Those Who Had Recovered From Natural Infection?

FEATURING Zijun Wang
  • March 24, 2021
12:45

Columbia University's Zuckerman Institute

[PRIVATE] SARS-CoV2 Variants: Should the Clinical Application of Monoclonal Antibodies and Vaccine Design Be Updated to Fight Viral Variants?

FEATURING Zijun Wang
  • 1 view
  • March 24, 2021
33:07

Columbia University's Zuckerman Institute

SARS-CoV-2 mRNA Vaccine: How Can This New Vaccine Help Future Vaccines to be Implemented Rapidly and Safely?

FEATURING Kizzmekia Corbett
  • 73 views
  • December 9, 2020
32:08

Columbia University's Zuckerman Institute

SARS-CoV-2 Transmission: What Is the Role of Clusters and Superspreading Events? What is Driving the Spread?

FEATURING Bronwyn Macinnis
  • 3,541 views
  • December 8, 2020
  • 7
36:01

Columbia University's Zuckerman Institute

COVID-19 & Computational Epidemiology: How Can Models Provide Real Forecasts and Risk Analysis for Infectious Disease Threats? What Are the Recent Results and Challenges With COVID-19?

FEATURING Alessandro Vespignani
  • 1,890 views
  • November 26, 2020
  • 4
31:31

Columbia University's Zuckerman Institute

How Structured Is the SARS-CoV-2 Genome? What Have We Learned and What Comes Next?

FEATURING Anna Pyle
  • 296 views
  • November 26, 2020
33:48

Columbia University's Zuckerman Institute

SARS-CoV-2 Specific T Cells: What Is Their Role During the First 30 Days of Infection? Are They Changing Over Time? Do Asymptomatic Individuals Have a Weaker T Cell Response?

FEATURING Antonio Bertoletti
  • 966 views
  • November 26, 2020
  • 3
24:17

Columbia University's Zuckerman Institute

Tackling COVID-19: Does Alpaca Nanobody Neutralize SARS-CoV-2?

FEATURING Gerald Mclnerney
  • 2,711 views
  • November 16, 2020
  • 14
27:16

Columbia University's Zuckerman Institute

COVID-19 Backup Vaccine: Can Exposure to HCoV Viruses Reduce the Severeness of COVID-19 Diseases?

FEATURING Andreas Thiel
  • 688 views
  • November 16, 2020
  • 2
24:38

Columbia University's Zuckerman Institute

SARS-CoV-2 Neutralizing Antibodies & Vaccine: How Do We Extract Antibodies and Test Them?

FEATURING Dennis Burton
  • 2,458 views
  • November 16, 2020
  • 5
16:53

Columbia University's Zuckerman Institute

COVID-19 Prevention: Can Coronavirus 3CL Proteases Prevent Protease-Mediated Cytotoxicity and Handle Pandemic in the Future?

FEATURING Samuel Resnick
  • 53 views
  • November 16, 2020
30:37

Columbia University's Zuckerman Institute

Simple, Cheap & Rapid COVID-19 Tests: How Important Are They for Safely Reopening Society?

FEATURING David Ho
  • 3,872 views
  • November 12, 2020
  • 17
27:30

Columbia University's Zuckerman Institute

SARS-CoV-2 in Companion Animals: What Are Susceptibility, Transmission, and Reinfection Rates in Domestic Cats?

FEATURING Jürgen A. Richt
  • 137 views
  • October 14, 2020
15:29

Columbia University's Zuckerman Institute

Severity Prediction in COVID-19: Can We Predict Disease Severity & Outcomes at Early Stage?

FEATURING Jay Lee
  • 575 views
  • October 14, 2020
  • 2
29:07

Columbia University's Zuckerman Institute

Corona & Corona-Like Viruses: What Kind of Virus Is γ-CoV Which Common in Birds, or Dangerous β-CoV Common in Bats? What Role Does Genome Play in Identifying Fundamental Parts and Common Virus Roots?

FEATURING Ben Neuman
  • 24 views
  • October 14, 2020
26:15

Columbia University's Zuckerman Institute

COVID-19: What Are the Benefits of Steroid + Antiviral Combination? Does Activation of Antiviral Response and Inhibition of Inflammasome Make a Difference?

FEATURING Dong-Yan Jin
  • 551 views
  • October 14, 2020
31:54

Columbia University's Zuckerman Institute

SARS-CoV-2 Transmission: What Aerosol Concentration and Size Distribution Is Right for Aspiration? What Is the Risk of Fecal Aerosols and Their Distribution?

FEATURING Yuguo Li
  • 3,298 views
  • October 14, 2020
  • 9
33:31

Columbia University's Zuckerman Institute

COVID-19 Resilience Plan (October Update): Is the End of the Pandemic Before 2024 More and More Unlikely?

FEATURING Irwin Redlener
  • 6,477 views
  • October 14, 2020
  • 14
31:59

Columbia University's Zuckerman Institute

SARS-CoV-2 Replication-Transcription Complex: What Is the Structural Basis for Helicase-Polymerase?

FEATURING Seth Darst
  • 24 views
  • October 5, 2020
28:07

Columbia University's Zuckerman Institute

SARS-CoV-2 Replication & Transcription: What Is the Biological Role of Helicase in Viral Replication?

FEATURING Elizabeth Campbell
  • 1,054 views
  • October 5, 2020
  • 4
27:29

Columbia University's Zuckerman Institute

Remdesivir vs. 3CLpro Inhibitor in SARS-CoV-2 Battle: Does 3CL Protease Inhibitor Have Superior Efficacy Compared to Remdesivir?

FEATURING Meike Dittmann
  • 841 views
  • October 1, 2020
  • 1
14:39

Columbia University's Zuckerman Institute

Sex Differences in COVID-19: Is There Any Difference in Viral Load or Antibodies in Male or Female?

FEATURING Akiko Iwasaki
  • 252 views
  • October 1, 2020
13:14

Columbia University's Zuckerman Institute

SARS-CoV-2 Immune Response: What Are the Disease Outcomes & Different Types of Immune Responses? Is There a Difference in Viral Load in Severe Disease vs. Moderate Disease?

FEATURING Akiko Iwasaki
  • 3,400 views
  • October 1, 2020
  • 19
31:53

Columbia University's Zuckerman Institute

COVID-19 SalivaDirectTM Test With 94.1% Accuracy: Will This Simple and Sensitive Molecular Diagnostic Test Be Able to Drastically Reduce the Turnaround Time on Testing?

FEATURING Anne Wyllie
  • 4,935 views
  • October 1, 2020
  • 15
31:35

Columbia University's Zuckerman Institute

Prefusion-Stabilized SARS-CoV-2 Spikes: Will High-Yield Production of a Stabilized Prefusion Spike Protein Accelerate the Development of Vaccines and Serological Diagnostics for SARS-CoV-2?

FEATURING Jason Mclellan
  • 81 views
  • September 23, 2020
13:47

Columbia University's Zuckerman Institute

SARS-CoV-2 Structural Analysis: Why is Cryo Electron Tomography Good Technique to Study Coronavirus and What Do We Know About Structure of S-Protein?

FEATURING Beata Turonova
  • 21 views
  • September 23, 2020
15:02

Columbia University's Zuckerman Institute

SARS-CoV-2 S-Protein 3D Structure Study: What Are the Different Virus Configurations? Why Is Discovery of Three Joints in Protein Important and What Does That Mean for Flexibility of the Virus?

FEATURING Mateusz Sikora
  • 34 views
  • September 23, 2020
27:27

Columbia University's Zuckerman Institute

SARS-CoV-2 3C and 3C-Like Protease Inhibitors Research: How Effective Is GC376i? Can Dipeptidyl Compound Series Serve as a Platform for Structure-Guided Design of Inhibitors Against Human Coronaviruses?

FEATURING Kyeong-Ok Chang
  • 40 views
  • September 23, 2020
08:49

Columbia University's Zuckerman Institute

NYP COVID-19 Experience: How Much Clinical Ethics Consultations Raised During Pandemic? What Were the Most Common Reasons for Consults and Patients Concerns?

FEATURING Katherine Fischkoff
  • 193 views
  • September 23, 2020
  • 1
13:55

Columbia University's Zuckerman Institute

NYP COVID-19 Ethics Consultations: Does COVID-19 Disproportionately Affect Minorities? How Important Is Legal Backup for Crisis Standard of Care?

FEATURING Lydia Dugdale
  • 25 views
  • September 23, 2020
31:45

Columbia University's Zuckerman Institute

SARS-CoV-2 Evolutionary Spike Potential: Can We Map the Effects of all Mutations on ACE2 Binding and RBD Expression? Are There Known ACE2 Receptor Mutations That Affect the Affinity and Could Impact the Clinical Effect of the Virus in Individual Patients?

FEATURING Jesse Bloom
  • 198 views
  • September 23, 2020
  • 1
10:53

Columbia University's Zuckerman Institute

COVID-19 Vaccine Trials Summary: Discussion and Q&A

FEATURING Daniel Lucey
  • 76 views
  • September 22, 2020
  • 1
28:40

Columbia University's Zuckerman Institute

D614G Mutation in SARS-CoV-2 Spike: Is the Virus Different and More Transmissible Than in March? Can G614 Be Useful as a Vaccine Antigen Because the RBD Is More Exposed?

FEATURING Bette Korber
  • 2,429 views
  • September 17, 2020
  • 10
14:05

Columbia University's Zuckerman Institute

Rapid Synthetic DNA SARS-CoV-2 Vaccine Analysis: What Are the Cellular and Humoral Immune Responses in Rhesus Monkeys and Side Effects of the Electroporation Delivery? Can We Use It in Children?

FEATURING Ami Patel
  • 1,440 views
  • September 17, 2020
  • 3
08:51

Columbia University's Zuckerman Institute

Development of a DNA SARS-CoV-2 Vaccine: What Are the Advantages of DNA and RNA Approaches for Rapid Vaccine Deployment?

FEATURING Ami Patel
  • 2,637 views
  • September 17, 2020
  • 7
24:07

Columbia University's Zuckerman Institute

COVID-19 Vaccine Trials on 6 Continents: Which Eight Vaccine Candidates Enrolled in Phase 3 Trials?

FEATURING Daniel Lucey
  • 4,655 views
  • September 16, 2020
  • 11
28:58

Columbia University's Zuckerman Institute

COVID-19 & School Reopening: What Test Will Allow Us to Safely Open College Campuses?

FEATURING A. David Paltiel, Rochelle Walensky
  • 3,282 views
  • September 3, 2020
  • 17
22:56

Columbia University's Zuckerman Institute

Can Hepatitis C Drugs Be Repurposed to Treat COVID-19? Which Drugs Are Furthest Ahead in Clinical Trials?

FEATURING Jingyue Ju
  • 1,168 views
  • September 3, 2020
  • 6
18:12

Columbia University's Zuckerman Institute

Physician Distress over COVID-19 Triage Decisions: Does Training Decrease Distress? How Should We Prepare Our Staff for a New Surge?

FEATURING Francisca Chou
  • 43 views
  • August 24, 2020
29:58

Columbia University's Zuckerman Institute

COVID-19 saRNA Vaccine: Is It Possible That There Is a Cheaper and Faster Solution?

FEATURING Robin J. Shattock
  • 3,363 views
  • August 24, 2020
  • 12
29:24

Columbia University's Zuckerman Institute

COVID-19 & Exacerbated Inflammatory Responses: Is Type I IFN Deficiency a Hallmark of Severe COVID-19?

FEATURING Benjamin Terrier
  • 27 views
  • August 24, 2020
22:00

Columbia University's Zuckerman Institute

Moving Around During the Pandemic: Should You Use Subway or Bike? Analyzing Choices of Transportation in NYC During COVID-19

FEATURING Juan Francisco Saldarriaga Chaux
  • 100 views
  • August 10, 2020
16:48

Columbia University's Zuckerman Institute

Green Disinfectant Foams & COVID-19: Can Disinfectant Products Increase the Risk of Chronic Lung Disease? Do Green Disinfection Foams Have the Potential in Multi-Faceting and Killing Viruses in Existence?

FEATURING Ponisseril Somasundaran
  • 1,418 views
  • August 10, 2020
  • 4
20:50

Columbia University's Zuckerman Institute

Synthetic Control Analysis of Post Memorial Day COVID-19 Outbreak in the US: Why Did it Happen? How Did Different Regions React to Lockdowns?

FEATURING Vishal Misra
  • 118 views
  • August 10, 2020
31:32

Columbia University's Zuckerman Institute

SARS-CoV-2 Spike: Can We Identify Convalescent Plasma Donors With High Ab Titers to Treat COVID-19? What Are the Correlates of Protection Afforded by CP? Can We Mine Convalescent B Donor Cells to Identify Potent Monoclonal Antibodies for Prophylaxis and Therapy?

FEATURING Kartik Chandran
  • 2,084 views
  • August 7, 2020
  • 5
29:10

Columbia University's Zuckerman Institute

Repurposed Drugs For COVID-19: Which Drugs Are In Trials & What Are The New Clinical Opps? How Can The Search For Treatment Be Accelerated?

FEATURING Arnab Chatterjee
  • 3,027 views
  • July 22, 2020
  • 8
13:55

Columbia University's Zuckerman Institute

COVID-19 & Pulmonary Embolism and Other Thrombotic Complications: Do Patients With COVID-19 Have an Increased Rate of Pulmonary Embolism?

FEATURING Kathleen M. Capaccione
  • 718 views
  • July 27, 2020
  • 2
13:06

Columbia University's Zuckerman Institute

Healing COVID-19 Lungs: How Do Stem Cells in the Lung Respond to the Damage? Can This Knowledge Be Used To Treat The Damage?

FEATURING Jianwen Que
  • 386 views
  • July 17, 2020
21:35

Columbia University's Zuckerman Institute

COVID-19 Testing: How Long Is Someone Infectious Enough To Be Able to Spread The Virus? How to Limit Undetected Infectious Days?

FEATURING Daniel Griffin
  • 21,208 views
  • July 17, 2020
  • 76
29:19

Columbia University's Zuckerman Institute

SARS-CoV-2 Epidemiology Update: How Has the Epidemiology of the Virus Changed Since Early March? Why Is Testing the Genome Important for Observing the Pandemic?

FEATURING Nathan Grubaugh
  • 552 views
  • July 1, 2020
  • 2
32:06

Columbia University's Zuckerman Institute

Global Health Vaccines for COVID-19: What Are the Non-medical Obstacles in Tackling This Pandemic & How Do We Work to Combat Them?

FEATURING Peter Hotez
  • 114 views
  • July 1, 2020
  • 2
25:04

Columbia University's Zuckerman Institute

Update on Airborne Transmission of SARS-CoV-2: Can Far UV Light Help Us Get Back to Business As Usual? Is it Safe for Prolonged Exposure?

FEATURING David Brenner
  • 18,938 views
  • June 18, 2020
  • 50
20:55

Columbia University's Zuckerman Institute

Coronavirus Reverse Genetics: What Have We Learned From 20 Years Of Coronavirus Research? How Long Does it Take to Clone A Coronavirus?

FEATURING Volker Thiel
  • 1,955 views
  • June 9, 2020
  • 4
11:24

Columbia University's Zuckerman Institute

SARS-CoV-2 & Ultraviolet Disinfection: Can Far-UVC Light Efficiently and Safely Inactivate Airborne Particles & Reduce Person-to-person SARS-CoV-2 Transmission?

FEATURING David Brenner
  • 15,042 views
  • June 9, 2020
  • 43
21:49

Columbia University's Zuckerman Institute

Factors that Regulate ACE2, the SARS-CoV-2 Entry Receptor: Which Cell Subsets Are Targeted by SARS-CoV-2? What Host Factors Are Involved in Regulating ACE2 Expression?

FEATURING José Ordovas-Montanes
  • 4,814 views
  • June 5, 2020
  • 13
32:44

Columbia University's Zuckerman Institute

Comprehensive Analysis of COVID-19 Immunology: How Much of an Adaptive Immune Response Is There to COVID-19? How Long Does the Immunological Memory to COVID-19 Last? What Kind of Immunity Is Important Against COVID-19?

FEATURING Shane Crotty
  • 6,438 views
  • June 4, 2020
  • 17
30:11

Columbia University's Zuckerman Institute

Mouse Models for COVID-19: What Do We Know About the CoV Immune Response & Can It Be Compared to MERS?

FEATURING Stanley Perlman
  • 218 views
  • May 28, 2020
  • 2
32:41

Columbia University's Zuckerman Institute

Massimo Baiocchi, MD and Maria Benedetto, MD - Intensive care organization, critical patient treatment in North Italian COVID Center

  • 38 views
  • May 27, 2020
22:26

Columbia University's Zuckerman Institute

Simulation & Projection of COVID-19 in the US: What Is the Metapopulation Model and How Does it Work? Can the Model Project Future Outcomes of the Disease?

FEATURING Jeffrey Shaman
  • 2,221 views
  • May 27, 2020
  • 7
14:52

Columbia University's Zuckerman Institute

Famotidine: How Can a Common Acid-Reducing Medication Be Used to Help Treat COVID-19? What Is the Science Behind This Peculiar Discovery?

FEATURING Daniel Freedberg
  • 5,702 views
  • May 27, 2020
  • 11
09:51

Columbia University's Zuckerman Institute

Which Drugs Are Showing Actual Efficacy in Killing the Virus? A Comprehensive Overview of New Therapies Against COVID-19

FEATURING Adolfo García-Sastre
  • 23,574 views
  • May 25, 2020
  • 40
17:48

Columbia University's Zuckerman Institute

SARS-CoV-2: What Is the Functional and Genetic Link Between Complement and Coagulation Functions and the Virus? Can a Specific C3 Inhibitor Be the Treatment We Have Been Looking for?

FEATURING Sagi Shapira
  • 2,996 views
  • May 18, 2020
  • 3
12:49

Columbia University's Zuckerman Institute

Can We Treat COVID-19 With 3CL Protease Inhibitor?

FEATURING Brent Stockwell
  • 412 views
  • May 18, 2020
  • 2
11:04

Columbia University's Zuckerman Institute

COVID-19 Autopsies: Who Is Getting Autopsied & What Is the Benefit on Treatment and General Knowledge About the Disease? Is There a COVID-19 Effect on Kidneys?

FEATURING Glen Markowitz
  • 33 views
  • May 18, 2020
15:42

Columbia University's Zuckerman Institute

Myocardial Injury During COVID-19: How Much Does It Affect Patient Outcomes & Can It Be Predicted With ECG?

FEATURING Nir Uriel
  • 1,068 views
  • May 18, 2020
  • 6
16:45

Columbia University's Zuckerman Institute

COVID-19 Clinical Experience: What Are the Less Known Complications & How Does the Cytokine Storm in SARS-CoV-2 Compare to the Original SARS?

FEATURING Daniel Griffin
  • 5,631 views
  • May 18, 2020
  • 26
15:22

Columbia University's Zuckerman Institute

COVID-19 Comprehensive Analysis: What Is the Time Course of the Disease & How Does It Compare To Influenza 2014-2019?

FEATURING George Hripcsak
  • 7,970 views
  • May 18, 2020
  • 16
14:40

Columbia University's Zuckerman Institute

What Can We Expect From the Daily Home Test for SARS-CoV-2 Infection and When Will It Be Available?

FEATURING Andrés Bendesky
  • 6,127 views
  • May 18, 2020
  • 12